Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

被引：0
|
作者：
Jeeyun Lee
Kyung Hae Jung
Young Suk Park
Joong Bae Ahn
Sang Jun Shin
Seock-Ah Im
Do Youn Oh
Dong Bok Shin
Tae Won Kim
Namsu Lee
Jae Ho Byun
Yong Sang Hong
Joon Oh Park
Se Hoon Park
Ho Yeong Lim
Won Ki Kang
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Research Institute and Hospital,Oncology, Department of Medicine, Samsung Medical Center
[3] Yonsei University College of Medicine,Center for Colorectal Cancer, National Cancer Center
[4] Seoul National University College of Medicine,Department of Internal Medicine
[5] Gachon University Gil Medical Center,Department of Internal Medicine
[6] University of Ulsan College of Medicine,Division of Hematology and Oncology, Department of Internal Medicine
[7] Soon Chun Hyang University Hospital,Division of Oncology, Department of Medicine, Asan Medical Center
[8] The Catholic University of Korea,Division of Hematology
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Statin; Simvastatin; Irinotecan; Cetuximab; Lovastatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：657 / 663
页数：6
相关论文
共 50 条
  • [21] FOLFOX (oxaliplatin and leucovorin plus fluorouracil) versus FOLFIRI (irinotecan and leucovorin plus fluorouracil) chemotherapy as a first-line treatment in a patients with unresectable metastatic or recurred gastric adenocarcinoma
    Tak, Dae Hyun
    Kim, Seok Hyun
    Moon, Hee Seok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 261 - 261
  • [22] Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer
    Sobrero, Alberto
    Ackland, Stephen
    Clarke, Stephen
    Perez-Carrion, Ramon
    Chiara, Silvia
    Gapski, John
    Mainwaring, Paul
    Langer, Bernd
    Young, Scott
    ONCOLOGY, 2009, 77 (02) : 113 - 119
  • [23] PHASE II STUDY OF FIRST-LINE SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN, LEUCOVORIN, AND 5-FLUOROURACIL (5-FU) (FOLFIRI) IN JAPANESE PATIENTS (PTS) WITH UNRESECTABLE/METASTATIC COLORECTAL CANCER (MCRC)
    Tsuji, A.
    Denda, T.
    Tsuji, Y.
    Satoh, T.
    Yoshida, M.
    Nishina, Y.
    Nagase, M.
    Komatsu, Y.
    Kato, T.
    Muro, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 199 - 200
  • [24] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [25] Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: A phase II trial
    Souglakos, J
    Pallis, A
    Kakolyris, S
    Mavroudis, D
    Androulakis, N
    Kouroussis, C
    Agelaki, S
    Xenidis, N
    Milaki, G
    Georgoulias, V
    ONCOLOGY, 2005, 69 (05) : 384 - 390
  • [26] A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy
    Sun Jin Sym
    Junshik Hong
    Jinny Park
    Eun Kyung Cho
    Jae Hoon Lee
    Yeon Ho Park
    Woon Ki Lee
    Min Chung
    Hyung-Sik Kim
    Se Hoon Park
    Dong Bok Shin
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 481 - 488
  • [27] A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy
    Sym, Sun Jin
    Hong, Junshik
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Park, Yeon Ho
    Lee, Woon Ki
    Chung, Min
    Kim, Hyung-Sik
    Park, Se Hoon
    Shin, Dong Bok
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (02) : 481 - 488
  • [28] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study
    Eric François
    Jean-François Berdah
    Emmanuel Chamorey
    Gérard Lesbats
    Eric Teissier
    Jean-François Codoul
    Jean-Luc Badetti
    Christophe Hébert
    Véronique Mari
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 931 - 936
  • [29] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer:: a Phase II study
    Francois, Eric
    Berdah, Jean-Francois
    Chamorey, Emmanuel
    Lesbats, Gerard
    Teissier, Eric
    Codoul, Jean-Francois
    Badetti, Jean-Luc
    Hebert, Christophe
    Mari, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 931 - 936
  • [30] Bevacizumab in combination with irinotecan, 5-fluorouracil and leucovorin given as first-line treatment of metastatic colorectal cancer
    Rocha, Jose Aurillo
    ANTI-CANCER DRUGS, 2011, 22 : S9 - S13
12345